Cancel
See Linkedin
Known information
- Has over 25 years of experience in senior finance roles
- Was Senior Vice President of Finance and Operations at Rubius Therapeutics
- Led financial aspects at Rubius Therapeutics and built infrastructure for substantial company growth
- Helped advance four programs into clinical trials and established a clinical manufacturing facility at Rubius Therapeutics
- Raised nearly $800 million in capital and transitioned Rubius Therapeutics from a private to a public company
- Served as Senior Vice President of Finance, New Ventures at Flagship Pioneering
- Was Chief Financial Officer of Novelos Therapeutics, a publicly held biotechnology company
- Spent 10 years with Ascential Software in various senior finance roles
- Started her career in the assurance practice at the Boston office of Deloitte & Touché LLP
- Holds a B.S. in business administration from Bryant University
- Is a Certified Public Accountant
About Alltrna
Alltrna is the world's first tRNA platform company, pioneering tRNA therapeutics to potentially treat thousands of diseases by targeting premature stop codons.
Report inaccurate information
